Page 8 - Stability Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cmc, chemistry manufacturing and controls and that's where the company has to show that the drug has good stability testing and they are waiting on the stability testing data to roll in in order to prolong the expiration date longer. now you would say this is absurd. the safety profile box has been checked, but the stability testing is something we are still waiting on. we don't need to know how long to extend expiration date, we need to send a message that 190 million americans have gotten vaccines with impeccable safety, that's the biggest bank that the government can do to increase vaccinat...

Problem is and how much everybody needs to get vaccinated and i agree with that conclusion. >> tammy: sure. >> this is a self-inflicted wound. the fda has not issued a full authorization and full approval of this vaccine. they have got 190 million measures who have gotten it and they have not issued a full approval. it's unacceptable. and truth be told, they are not waiting on the safety profile to be evaluated. they're waiting on something called the stability testing. it's part of the chemistry manufacturing and controlled section of the application it's to evaluate how long they can extend ...

Next to them looks like. it matter. final thought? >> right now, if we want to get more people vaccinated stop trying to cover up all these young kids that are healthy, fda should give full approval to the vaccines, we have been waiting on that bureaucracy. another giant health bureaucracy. they have two things they do to give full approval. one is confirm safety. that's done. that box is checked. the other is that the stability testing. we don't need that data right now. go ahead and give the full approval. then we will see if vaccination rates go up a lot faster. >> brian: the guy in charge ...

Search jobs 11-Mar-2021 US Clinical Trial Management System Market 2021, Size, Share, Analysis, Upcoming Trends, Latest Innovations, Growth, Key Players and Competitive Strategies – Forecast to 2027 Pune, Maharashtra, India, March 11 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Clinical Trial Management System Market is valued at USD 745.86 Million in 2020 and expected to reach USD 1711.70 Million by 2027 with a CAGR of 12.60% over the forecast period. US Clinical Trial Management System Market: US Size, Trends, Com...

Search jobs UK Diabetes Insulin Delivery Pens Market Size | Industry Analysis and Opportunity Assessment 2021-2027 Pune, Maharashtra, India, March 11 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Diabetes Insulin Delivery Pens Market is valued at USD 3868.4 Million in 2018 and expected to reach USD 6847.6 Million by 2025 with a CAGR of 8.50% over the forecast period. – Rising awareness about advanced insulin delivery devices among diabetic patients will augment the demand for diabetes insulin delivering pens. Market Analysis of ...